• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺少酪氨酸激酶结构域的Flt-1对小鼠的正常发育和血管生成来说足够了。

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

作者信息

Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M

机构信息

Department of Genetics, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

出版信息

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54. doi: 10.1073/pnas.95.16.9349.

DOI:10.1073/pnas.95.16.9349
PMID:9689083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC21341/
Abstract

Receptor tyrosine kinases Flt-1 and Flk-1/KDR, and their ligand, the vascular endothelial growth factor (VEGF), were shown to be essential for angiogenesis in the mouse embryo by gene targeting. Flk-1/KDR null mutant mice exhibited impaired endothelial and hematopoietic cell development. On the other hand, Flt-1 null mutation resulted in early embryonic death at embryonic day 8.5, showing disorganization of blood vessels, such as overgrowth of endothelial cells. Flt-1 differs from Flk-1 in that it displays a higher affinity for VEGF but lower kinase activity, suggesting the importance of its extracellular domain. To examine the biological role of Flt-1 in embryonic development and vascular formation, we deleted the kinase domain without affecting the ligand binding region. Flt-1 tyrosine kinase-deficient homozygous mice (flt-1(TK-/-)) developed normal vessels and survived. However, VEGF-induced macrophage migration was strongly suppressed in flt-1(TK-/-) mice. These results indicate that Flt-1 without tyrosine kinase domain is sufficient to allow embryonic development with normal angiogenesis, and that a receptor tyrosine kinase plays a main biological role as a ligand-binding molecule.

摘要

通过基因靶向技术已证明,受体酪氨酸激酶Flt-1和Flk-1/KDR及其配体血管内皮生长因子(VEGF)对小鼠胚胎血管生成至关重要。Flk-1/KDR基因敲除突变小鼠表现出内皮细胞和造血细胞发育受损。另一方面,Flt-1基因敲除突变导致胚胎在第8.5天早期死亡,出现血管紊乱,如内皮细胞过度生长。Flt-1与Flk-1的不同之处在于,它对VEGF具有更高的亲和力,但激酶活性较低,这表明其细胞外结构域的重要性。为了研究Flt-1在胚胎发育和血管形成中的生物学作用,我们删除了激酶结构域,同时不影响配体结合区域。Flt-1酪氨酸激酶缺陷型纯合小鼠(flt-1(TK-/-))发育出正常血管并存活下来。然而,在flt-1(TK-/-)小鼠中,VEGF诱导的巨噬细胞迁移受到强烈抑制。这些结果表明,没有酪氨酸激酶结构域的Flt-1足以支持正常血管生成的胚胎发育,并且受体酪氨酸激酶作为配体结合分子发挥主要生物学作用。

相似文献

1
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.缺少酪氨酸激酶结构域的Flt-1对小鼠的正常发育和血管生成来说足够了。
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54. doi: 10.1073/pnas.95.16.9349.
2
Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.血管内皮生长因子受体-1(flt-1)及其配体的协同表达提示了对小鼠血管发育的旁分泌调节。
Dev Dyn. 1995 Nov;204(3):228-39. doi: 10.1002/aja.1002040303.
3
Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.Flt-1而非KDR/Flk-1酪氨酸激酶是胎盘生长因子的受体,胎盘生长因子与血管内皮生长因子相关。
Cell Growth Differ. 1996 Feb;7(2):213-21.
4
Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).血管内皮生长因子受体-1(Flt-1酪氨酸激酶)细胞外结构域的特征分析
Jpn J Cancer Res. 1997 Sep;88(9):867-76. doi: 10.1111/j.1349-7006.1997.tb00463.x.
5
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.Flt-1(血管内皮生长因子受体-1)和KDR(血管内皮生长因子受体-2)的生物学效应及信号特性分析。使用新型受体特异性血管内皮生长因子突变体的重新评估
J Biol Chem. 2001 Feb 2;276(5):3222-30. doi: 10.1074/jbc.M002016200. Epub 2000 Oct 31.
6
Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.血管内皮生长因子-弗林蛋白酶酪氨酸激酶受体系统在正常及肿瘤血管生成中的可能作用。
Princess Takamatsu Symp. 1994;24:162-70.
7
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.Flt-1受体酪氨酸激酶在调节血管内皮组装中的作用。
Nature. 1995 Jul 6;376(6535):66-70. doi: 10.1038/376066a0.
8
A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).一种通过血管内皮生长因子和Flt酪氨酸激酶受体家族(Flt-1和KDR/Flk-1)在肝脏中肝细胞与窦状内皮细胞之间建立的新型通讯系统。
Oncogene. 1994 Sep;9(9):2683-90.
9
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.VEGF基因靶向失活诱导的杂合子胚胎致死性
Nature. 1996 Apr 4;380(6573):439-42. doi: 10.1038/380439a0.
10
Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.在血管内皮生长因子(VEGF)刺激血管内皮细胞后,Src激酶优先与血管内皮生长因子受体(VEGFR)、激酶插入域受体(KDR)/胎儿肝激酶1(Flk-1)结合。
BMC Biochem. 2002 Dec 31;3:32. doi: 10.1186/1471-2091-3-32.

引用本文的文献

1
Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.抑制腹膜巨噬细胞中的VEGFR1酪氨酸激酶信号可抑制子宫内膜异位症的发展。
In Vivo. 2025 Sep-Oct;39(5):2584-2598. doi: 10.21873/invivo.14059.
2
VEGFR1 as a Target for Cardiovascular Gene Therapy.血管内皮生长因子受体1作为心血管基因治疗的靶点
J Cardiovasc Transl Res. 2025 Aug 21. doi: 10.1007/s12265-025-10672-5.
3
Mechanistic computational modeling of sFLT1 secretion dynamics.sFLT1分泌动力学的机制性计算建模
PLoS Comput Biol. 2025 Aug 18;21(8):e1013324. doi: 10.1371/journal.pcbi.1013324. eCollection 2025 Aug.
4
Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells.配体结合对人内皮细胞中VEGFR1、VEGFR2和NRP1定位的影响。
PLoS Comput Biol. 2025 Jul 16;21(7):e1013254. doi: 10.1371/journal.pcbi.1013254. eCollection 2025 Jul.
5
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.健康与疾病中的血管内皮生长因子信号传导:从分子机制到治疗前景
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
6
Activin a regulates vascular formation and stabilization in direct coculture of dental pulp stem cells and endothelial cells.激活素A在牙髓干细胞与内皮细胞的直接共培养中调节血管形成与稳定。
Int Endod J. 2025 Jul;58(7):991-1005. doi: 10.1111/iej.14226. Epub 2025 Mar 19.
7
Mechanistic computational modeling of sFLT1 secretion dynamics.sFLT1分泌动力学的机制性计算建模
bioRxiv. 2025 Feb 18:2025.02.12.637983. doi: 10.1101/2025.02.12.637983.
8
Vascular regional analysis unveils differential responses to anti-angiogenic therapy in pancreatic xenografts through macroscopic photoacoustic imaging.血管区域分析通过宏观光声成像揭示了胰腺异种移植瘤对抗血管生成治疗的不同反应。
Theranostics. 2025 Jan 27;15(6):2649-2671. doi: 10.7150/thno.99361. eCollection 2025.
9
Association of ten VEGF family genes with Alzheimer's disease endophenotypes at single cell resolution.单细胞分辨率下十个VEGF家族基因与阿尔茨海默病内表型的关联
Alzheimers Dement. 2025 Feb;21(2):e14419. doi: 10.1002/alz.14419. Epub 2024 Dec 6.
10
Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications.可溶性 FLT-1 在血管生成中的作用:病理生理作用和治疗意义。
Angiogenesis. 2024 Nov;27(4):641-661. doi: 10.1007/s10456-024-09942-8. Epub 2024 Aug 29.

本文引用的文献

1
Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors.编码血管内皮生长因子(VEGF)受体-1的flt-1基因的基因组组织表明,7-Ig酪氨酸激酶受体和5-Ig酪氨酸激酶受体之间存在密切的进化关系。
Gene. 1998 Feb 27;208(2):297-305. doi: 10.1016/s0378-1119(98)00006-7.
2
Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).血管内皮生长因子受体-1(Flt-1酪氨酸激酶)细胞外结构域的特征分析
Jpn J Cancer Res. 1997 Sep;88(9):867-76. doi: 10.1111/j.1349-7006.1997.tb00463.x.
3
Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice.在脑源性神经营养因子、神经营养素3和TrkC基因缺陷的胚胎小鼠中,在靶神经支配之前感觉神经元缺失。
J Neurosci. 1997 Dec 1;17(23):9113-21. doi: 10.1523/JNEUROSCI.17-23-09113.1997.
4
The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma.Flt-1激酶(血管内皮生长因子受体-1,VEGFR-1)含磷酸化1169位酪氨酸的区域是磷脂酶Cγ(PLCγ)的主要结合位点。
Biochem Biophys Res Commun. 1997 Sep 18;238(2):487-91. doi: 10.1006/bbrc.1997.7327.
5
The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.KDR/Flk-1(血管内皮生长因子受体-2)的230 kDa成熟形式激活PLC-γ途径,并在NIH3T3成纤维细胞中部分诱导有丝分裂信号。
Oncogene. 1997 May 1;14(17):2079-89. doi: 10.1038/sj.onc.1201047.
6
Mechanisms of angiogenesis.血管生成的机制。
Nature. 1997 Apr 17;386(6626):671-4. doi: 10.1038/386671a0.
7
Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.血管内皮生长因子受体FLT-1胞外域配体结合位点及受体二聚化位点的定位
J Biol Chem. 1997 Apr 18;272(16):10382-8. doi: 10.1074/jbc.272.16.10382.
8
Oncoprotein networks.癌蛋白网络
Cell. 1997 Feb 7;88(3):333-46. doi: 10.1016/s0092-8674(00)81872-3.
9
The biology of vascular endothelial growth factor.血管内皮生长因子的生物学
Endocr Rev. 1997 Feb;18(1):4-25. doi: 10.1210/edrv.18.1.0287.
10
Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development.体内Grb2与Met受体的解偶联揭示了其在肌肉发育中的复杂作用。
Cell. 1996 Nov 1;87(3):531-42. doi: 10.1016/s0092-8674(00)81372-0.